Refractory precursor T-lymphoblastic lymphoma/leukemia
MONDO:0004404T-lymphoblastic leukemia/lymphoma resistant to treatment
Also known as: precursor T lymphoblastic lymphoma/leukemia refractory, refractory T lymphoblastic leukemia/lymphoma, refractory precursor T-lymphoblastic lymphoma/leukemia
1888 clinical trials for this condition and its sub-types, 31 tagged with Refractory precursor T-lymphoblastic lymphoma/leukemia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Experimental CAR-T therapy targets tough childhood blood cancers
Disease control Not yet recruitingThis early-phase trial is testing a new treatment called PA3-17 injection for children and teens aged 3 to 18 with T-cell leukemia or lymphoma that has not responded to standard therapy or has come back. The treatment uses the patient's own immune cells, modified to recognize and…
Phase 1 • Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Engineered immune cells take aim at tough blood cancers
Disease control Not yet recruitingThis early study tests a new treatment using the body's own immune cells, called CAR-T cells, to fight certain blood cancers (like T-cell leukemia/lymphoma) that have returned or not responded to standard therapy. The study will enroll about 20 to 28 adults aged 18-85. The main g…
Sponsor: Donghua Zhang • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Promising drug cocktail targets tough childhood cancers
Disease control Not yet recruitingThis trial tests a combination of three drugs—capivasertib, venetoclax, and dexamethasone—in children and young adults with relapsed or refractory acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LBL). The study has two phases: first, to find the safest dose, and sec…
Phase 1/2 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Disease control
Last updated Jun 26, 2026 17:34 UTC